DAVID GRANOVSKY

Archive for April 14th, 2009|Daily archive page

Eva Green in WOMB decides to clone her husband Dr Who – Eva Green Advances Stem Cell Research

In ALL ARTICLES, CELEBRITIES & STEM CELLS on April 14, 2009 at 10:13 pm

By Katey Rich: 2009-02-09 14:06:43

Eva Green Advances Stem Cell Research I figure we’ve all been missing Eva Green since Casino Royale, and especially since none of us saw her follow-up film, The Golden Compass. And true to a girl whose breakout role was the crazy-sexy-weird The Dreamers, Green has now signed on to a project that straddles that line between fascinating and bizarre.

The project is Womb, a futuristic drama that will be the English-language debut of Benedek Fliegauf, a Hungarian director who’s made some impact at the Berlin Film Festival in the past. Variety reports that Green will play a grieving widow who decides to clone her husband; the new Dr. Who, Matt Smith, will play the not-quite-dead guy.

It’s hard to deny the appeal of Dr. Who and Vesper Lynd together, even if the movie potentially makes no sense. More likely, it’ll be artsy and strange and barely get seen over here, given that it’s an English-language debut and all. But Eva Green fans can keep dreaming anyway.

via Eva Green Advances Stem Cell Research.

IZumi, Japanese university unite to refine stem cell technique – Related Stories – BIO SmartBrief

In ALL ARTICLES, BUSINESS OF STEM CELLS on April 14, 2009 at 8:12 pm

shake-on-it-japan-izumi bio

IZumi, Japanese university unite to refine stem cell technique

BIO SmartBrief | 04/14/2009

IZumi Bio in California is collaborating with Kyoto University in Japan to further develop and commercialize a technique for converting mature human cells into an embryonic like state. The procedure, known as cellular reprogramming, might lead to speedier drug discovery by allowing testing of experimental medicines against newly created cell lines from patients. Wall Street Journal, The (04/14)

via IZumi, Japanese university unite to refine stem cell technique – Related Stories – BIO SmartBrief.

Former Vice President Gore Jumps Into Stem Cell Research

In ALL ARTICLES, STEM CELLS IN THE NEWS on April 14, 2009 at 6:01 pm

gore-ips-cells

Former Vice President Gore Jumps Into Stem Cell Research

Tuesday, Apr 14, 2009 @09:30am CST

Former Vice President Al Gore is interested in more than global warming issues.

Today he’ll put his name behind a 20-million dollar venture involving stem cell research.

“USA Today” says the program will involve an alternative to embryonic stem cells called “induced pluripotent” stem cells.

Mr. Gore says the cells are “filled with promise and hope.” He says, quote, “I think this is one of those good news stories that comes along every once in a while.”

When he was a member of Congress in the 1970s and 80s, Gore was involved in hearings on medical uses of cell technologies.

Now he’s a partner with a venture-capital firm, Kleiner Perkins Caufield and Byers.

That group will work with researcher Shinya Yamanaka of Kyoto University.

The scientist announced three years ago he’d developed a way to reprogram skin cells, creating something close enough to an embryonic cell that it has potential to grow transplantable organs.

The first efforts will zero in on cells with genetic markers for Parkinson’s and a couple of lesser known diseases in hopes of finding a cure.

via Former Vice President Gore Jumps Into Stem Cell Research.

Scientists in Canada, Japan sign research pact for stem cells – Related Stories – BIO SmartBrief

In ALL ARTICLES on April 14, 2009 at 3:52 pm

shake-on-it-copy

Scientists in Canada, Japan sign research pact for stem cells

BIO SmartBrief | 10/17/2008

The University of Toronto and Kyoto University have entered into a research-sharing deal aimed at speeding up the development of stem cell treatments for conditions such as cystic fibrosis and autism. The partnership will allow researchers to share technologies, protocols and patient specimens, an official with the Canadian institution said. Google (10/17)

via Scientists in Canada, Japan sign research pact for stem cells – Related Stories – BIO SmartBrief.

A Father’s Quest to Cure His Daughter – Well Blog – NYTimes.com

In ALL ARTICLES, VICTORIES & SUCCESS STORIES on April 14, 2009 at 1:45 pm

spinal cord column paralysis

April 14, 2009, 11:08 am

A Father’s Quest to Cure His Daughter

Stem cell research has been getting a lot of attention lately. Last month, President Obama lifted the Bush administration’s strict limits on human embryonic stem cell research. The actor Michael J. Fox recently appeared on “The Daily Show” promoting his new book and the need for stem cell studies.

And recently the prestigious Peabody awards, issued for excellence in electronic media, recognized a moving independent film, “Mapping Stem Cell Research: Terra Incognita.” The documentary explores the science, emotions and ethical complications of stem cell research through the story of a scientist who focused his research efforts on spinal cord injury after his daughter became paralyzed in a skiing accident.

Tonight, The New School in Manhattan will offer a free screening of “Terra Incognita,” followed by a discussion with the filmmakers and scientists involved. (Click on the highlighted link for details.) To see a trailer of the film, click on the link below:

via A Father’s Quest to Cure His Daughter – Well Blog – NYTimes.com.

Stem Cells in the City: Science, Narratives, and Film

Terra Incognita: Mapping Stem Cell Research Screening and Discussion

Sponsored by Eugene Lang College and Project Pericles

Advances in stem cell research are occurring at a dizzying pace, yet many argue the field is not moving fast enough, while others ask for a more measured pace. Who are the stakeholders and why do they have such different views?

Join the New School for the film screening of the feature length documentary film Terra Incognita, which provides an inside look into the lives of stem cell researchers and the fierce competition for being the first to make a breakthrough. The film follows the constantly evolving interplay between the promise of new discoveries, the controversy of modern science and the resilience and courage of people living every day with devastating disease and injury.

For more details visit http://www.kartemquin.com/films/terra-incognita.

Discussants:

Maria Finizto, Director and Producer of Terra Incognita

Xiao Hu, New York Stem Cell Foundation Druckenmiller Fellow, Albert Einstein College of Medicine

Brian Newman, CEO of Tribeca Film Institute

Alexis Gambis, Cancer Genetics, Rockefeller University, Artistic Director and Founder, Imagine Science Film Festival, and Sloan Film Advisory Committee Member

Moderator: Katayoun Chamany, Associate Professor of Biology, Eugene Lang College, The New School for Liberal Arts

Job for Candidate with MBA/Biology background

In ALL ARTICLES on April 14, 2009 at 1:16 pm

employment job hire candidate mba biology backgroundOne of the companies I am working for is looking to hire a number of people with an MBA or other business degree and a medical background.  MBA and radiology are ideal but they are willing to consider anyone who has a biology background.  Let me know if you can think of someone who fits the bill.  I can provide detailed info on the company and their goals.

Cntact me at the email below.
Thanks for your help-
David

dsgrano@gmail.com

Study: Stem Cells May Reverse Type 1 Diabetes – TIME

In ALL ARTICLES, VICTORIES & SUCCESS STORIES on April 14, 2009 at 12:31 pm
A stem cell treatment allows the regrowth of insulin-producing Beta cells in type 1 diabetes patients

A stem cell treatment allows the regrowth of insulin-producing Beta cells in type 1 diabetes patients

Study: Stem Cells May Reverse Type 1 Diabetes

By Alice Park Monday, Apr. 13, 2009, Biophoto Associates / Photo Researchers

Researchers have used injections of patients’ own stem cells to reverse the course of type 1 diabetes, reports a research team from the University of São Paulo in Brazil and Northwestern University in Chicago.

The findings, published in the current issue of the Journal of the American Medical Association, exemplify the remarkable gains made by diabetes researchers, who are battling a continuously spreading disease that now affects nearly 8% of adults and children. (See the top 10 medical breakthroughs of 2008.)

The research team, led by Dr. Julio Voltarelli of the University of Sao Paulo, is the first to successfully treat type 1 diabetes patients with their own stem cells. The group first reported its initial achievement in 2007, with 15 type 1 diabetes patients who received their own stem cells and no longer needed insulin to control their blood sugar levels.

In the new study, a follow-up of their previous work, Voltarelli and his colleagues detailed the same success with an additional eight patients, and also confirmed that in the majority of them, the stem cell transplant led to an appreciable repopulation of functioning insulin-producing beta cells in the pancreas.

via Study: Stem Cells May Reverse Type 1 Diabetes – TIME.

Miracle jab that heals bones twice as fast will revolutionise treatment, say doctors | Mail Online

In ALL ARTICLES, VICTORIES & SUCCESS STORIES on April 14, 2009 at 12:02 pm

broken-leg

Doctors hail ‘miracle jab’ that will heal adult’s bones as fast as children’s

By Fiona Macrae

Last updated at 4:22 PM on 14th April 2009

A ‘miracle’ jab that spurs adults’ bone into healing as quickly as children’s stands to transform the treatment of fractures, doctors believe.

The drug teriparatide more than doubles the speed at which broken bones mend – and slashes pain, a study found.

Researchers described some of the recoveries as ‘miraculous’, with patients confined to wheelchairs by long-standing fractures able to walk again.

They say teriparatide, which is already used to prevent osteoporosis, could have a profound impact on the treatment of broken bones.

Miracle jab: Teriparatide doubles the speed at which broken bones mend

via Miracle jab that heals bones twice as fast will revolutionise treatment, say doctors | Mail Online.

STEM CELL Transplants help Type 1 diabetics skip insulin | Health | Reuters

In ALL ARTICLES, VICTORIES & SUCCESS STORIES on April 14, 2009 at 6:24 am

insulin-syringe-no-more

STEM CELL Transplants help Type 1 diabetics skip insulin

CHICAGO (Reuters) – People with type 1 diabetes who got stem cell transplants were able to go as long as four years without needing insulin treatments, U.S. researchers said on Tuesday.

They said the process, which involves injecting people with stem cells made from their bone marrow cells, appears to have a lasting effect.

The study involved patients with Type 1 diabetes, formerly called juvenile diabetes, which occurs when the immune system goes haywire and starts attacking itself, destroying insulin-producing cells in the pancreas needed to control blood sugar.

These patients typically need daily insulin therapy to control their diabetes.

Dr. Richard Burt of Northwestern University’s Feinberg School of Medicine in Chicago and colleagues first reported on the short-term success of the procedure, known as autologous non-myeloablative hematopoietic stem-cell transplantation, in 2007 but have since looked at how long it persisted.

Writing in this week’s Journal of the American Medical Association they said 20 of 23 patients “became insulin free — 12 continuously and eight transiently — for periods as long as four years.” The transient group of eight had to restart insulin at reduced levels.

The patients ranged in age from 13 to 31.

To find out if the change was lasting the research team said they measured levels of C-peptides, which show how well the body is producing insulin. They found those levels increased “up to 24 months after transplantation and were maintained until at least 36 months,” their report said.

Even in the group which had to restart insulin there was still a significant increase in C-peptide levels that lasted at least two years, the researchers said.

They said the procedure was able to induce “prolonged and significant increases of C-peptide levels” in the small group of patients who were taking little or no insulin.

“At the present time (it) remains the only treatment capable of reversing type 1 diabetes mellitus in humans,” the team wrote.

“Randomized controlled trials and further biological studies are necessary to confirm the role of this treatment in changing the natural history of (the disease),” they added.

(Editing by Julie Steenhuysen and Alan Elsner)

via Transplants help Type 1 diabetics skip insulin | Health | Reuters.

%d bloggers like this: